- Home
- NWTG vs EVOK Comparison
NWTG vs EVOK Comparison
Compare NWTG & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTG
- EVOK
- Stock Information
- Founded
- NWTG 2018
- EVOK 2007
- Country
- NWTG United States
- EVOK United States
- Employees
- NWTG N/A
- EVOK N/A
- Industry
- NWTG Recreational Games/Products/Toys
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- NWTG Consumer Discretionary
- EVOK Health Care
- Exchange
- NWTG Nasdaq
- EVOK Nasdaq
- Market Cap
- NWTG 7.1M
- EVOK 7.6M
- IPO Year
- NWTG N/A
- EVOK 2013
- Fundamental
- Price
- NWTG $1.36
- EVOK $10.70
- Analyst Decision
- NWTG
- EVOK
- Analyst Count
- NWTG 0
- EVOK 0
- Target Price
- NWTG N/A
- EVOK N/A
- AVG Volume (30 Days)
- NWTG 64.4K
- EVOK 235.3K
- Earning Date
- NWTG 11-13-2025
- EVOK 11-07-2025
- Dividend Yield
- NWTG N/A
- EVOK N/A
- EPS Growth
- NWTG N/A
- EVOK N/A
- EPS
- NWTG N/A
- EVOK N/A
- Revenue
- NWTG $5,560,000.00
- EVOK $12,794,859.00
- Revenue This Year
- NWTG $117.56
- EVOK $57.38
- Revenue Next Year
- NWTG $51.43
- EVOK $59.57
- P/E Ratio
- NWTG N/A
- EVOK N/A
- Revenue Growth
- NWTG 304.36
- EVOK 70.02
- 52 Week Low
- NWTG $1.25
- EVOK $1.94
- 52 Week High
- NWTG $59.70
- EVOK $10.79
- Technical
- Relative Strength Index (RSI)
- NWTG 32.91
- EVOK 84.11
- Support Level
- NWTG $1.25
- EVOK $4.50
- Resistance Level
- NWTG $1.35
- EVOK $10.73
- Average True Range (ATR)
- NWTG 0.09
- EVOK 0.25
- MACD
- NWTG -0.01
- EVOK 0.55
- Stochastic Oscillator
- NWTG 18.00
- EVOK 98.25
About NWTG Newton Golf Company Inc. Common Stock
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.